Arkstone Antimicrobial Stewardship
Arkstone is a leader in antimicrobial stewardship and infectious disease management, offering advanced solutions that empower healthcare providers to make precise, informed treatment decisions. Their flagship tool, the OneChoice report, combines clinical expertise with sophisticated algorithms to analyze lab results and recommend targeted antimicrobial therapies. By delivering concise, actionable insights, Arkstone helps healthcare providers reduce unnecessary antibiotic use, thereby improving patient outcomes and supporting efforts to combat antimicrobial resistance.
Joint Value of Dendi LIS and Arkstone Integration
Hundreds of Dendi’s lab clients are utilizing Arkstone’s OneChoice report through Dendi LIS to strengthen clinical decision support, advance infectious disease management, and support antibiotic stewardship. Integrated seamlessly within Dendi for delivery, the OneChoice report provides clinicians with real-time, evidence-based recommendations, enabling precise, patient-specific treatments.
This empowers healthcare providers to actively participate in antimicrobial stewardship programs by promoting responsible antibiotic use and helping to mitigate resistance. Together, Dendi and Arkstone provide labs with a powerful tool that enhances patient care, supports stewardship initiatives, and contributes to the broader mission of sustainable healthcare practices.
Contact us to explore how our joint solution can elevate your lab business today.
Learn more at: https://arkstone.ai/report/
